Skip to main navigation Skip to search Skip to main content

Six-month therapy for abdominal tuberculosis

  • Sophie Jullien
  • , Siddharth Jain
  • , Hannah Ryan
  • , Vineet Ahuja
  • Liverpool School of Tropical Medicine

Research output: Contribution to journalReview articlepeer-review

33 Citations (Scopus)

Abstract

This is a protocol for a Cochrane Review (Intervention). The objectives are as follows:

To compare the effects of six-month versus longer regimens for abdominal tuberculosis (TB), consisting of a two-month intensive phase with rifampicin, isoniazid, pyrazinamide, and ethambutol followed by a four-month or longer continuation phase including at least isoniazid and rifampicin.

Original languageEnglish
Article numberCD012163
Pages (from-to)CD012163
JournalCochrane Database of Systematic Reviews
Volume2016
Issue number11
DOIs
Publication statusPublished - 1 Nov 2016

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Six-month therapy for abdominal tuberculosis'. Together they form a unique fingerprint.

Cite this